In humans, intranasal delivery of NGF has been recently investigated both in a child with severe TBI and in 3 children with chronic vegetative state secondary to prolonged out-hospital cardiac arrest, with a significant improvement both of their cognitive and motor functions after the treatment [27, 29]. This evidence concerns the gene NGF and cardiac arrest.